HR 2026
115th Congress
House
Health
Drug safety, medical device, and laboratory regulation
Fraud offenses and financial crimes
Health information and medical records
Medical research
Pharmaceutical Information Exchange Act
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 17, 2018
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .
Jan 17, 2018
Subcommittee Consideration and Mark-up Session Held.
Apr 7, 2017
Referred to the Subcommittee on Health.
Apr 6, 2017
Referred to the House Committee on Energy and Commerce.
Apr 6, 2017
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Pharmaceutical Information Exchange Act
This bill amends the Federal Food, Drug, and Cosmetic Act to allow information about a new investigational medication or the investigational use of a medication approved by the Food and Drug Administration to be provided to health care entities if the information is based on reliable scientific evidence.
What's happening now
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 2026: Pharmaceutical Information Exchange Act. 115th Congress. Open America. https://openamerica.io/bill/115-HR-2026/
"H.R. 2026: Pharmaceutical Information Exchange Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-2026/.
H.R. 2026, 115th Cong. (2026), https://openamerica.io/bill/115-HR-2026/.
[H.R. 2026: Pharmaceutical Information Exchange Act](https://openamerica.io/bill/115-HR-2026/)